SearchDictionaryMobileLogin

Yuji Matsuzawa Selected Research

Adiponectin

04/2008Prognostic value of adiponectin for cardiovascular disease and mortality.
01/2008Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease.
07/2007A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
04/2007The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes.
03/2006Adiponectin: a key adipocytokine in metabolic syndrome.
12/2005Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
09/2005Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism.
07/2005Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders.
05/2005Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.
05/2005Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.
01/2005Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma.
01/2005Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study.
11/2004Adiponectin as a biomarker of the metabolic syndrome.
04/2004Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
03/2004[Involvement of adiponectin in the pathogenesis of hypertension and hypertensive target-organ damage]
01/2004Adiponectin and metabolic syndrome.
12/2003Obesity, adiponectin and vascular inflammatory disease.
12/2003Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.
11/2003Association of serum adiponectin levels with breast cancer risk.
08/2003A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin.
06/2003Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
05/2003Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
04/2003Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.
01/2003Decreased plasma adiponectin concentration in patients with essential hypertension.
11/2002Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
11/2002Plasma adiponectin levels in overweight and obese Asians.
10/2002Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.
10/2002Plasma adiponectin concentrations in children: relationships with obesity and insulinemia.
10/2002Low plasma adiponectin concentrations do not predict weight gain in humans.
09/2002Adiponectin in essential hypertension.
07/2002[Adiponectin as a key molecule of the metabolic syndrome]
07/2002Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome.
07/2002Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
05/2002Serum adiponectin and leptin levels in patients with lipodystrophies.
01/2002Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Articles by Research Topic

Disease

12Syndrome
04/2007 - 07/2002
8Obesity
03/2007 - 04/2002
7Hypercholesterolemia
08/2008 - 01/2002
6Insulin Resistance
07/2007 - 07/2002
4Lipodystrophy
06/2004 - 05/2002
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2008 - 04/2002
3Atherosclerosis (Atheroma)
01/2005 - 11/2002
3Hypertension (High Blood Pressure)
03/2004 - 09/2002
2Cardiovascular Diseases (Cardiovascular Disease)
04/2008 - 01/2006
2Overweight
12/2005 - 11/2002
2Chronic Kidney Failure (Chronic Renal Failure)
01/2005 - 01/2002
2Nephrotic Syndrome (Syndrome, Nephrotic)
08/2003 - 05/2003
1Stroke (Strokes)
07/2008
1Type 2 Diabetes Mellitus (MODY)
04/2007
1Heart Failure
09/2005
1Adenoma (Adenomas)
05/2005
1Vascular Diseases (Vascular Disease)
05/2005
1Arteriosclerosis
03/2004
1Hepatocellular Carcinoma (Hepatoma)
12/2003
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2003
1Breast Neoplasms (Breast Cancer)
11/2003
1Cushing Syndrome
10/2003
1Carcinoid Tumor (Carcinoid)
10/2003
1Takayasu Arteritis (Arteritis, Takayasu's)
09/2003
1Hyperlipoproteinemias
06/2003
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2003
1Body Weight (Weight, Body)
01/2003
1Coronary Disease (Coronary Heart Disease)
12/2002
1Pathologic Constriction (Stenosis)
10/2002
1Weight Gain
10/2002
1Meningoencephalitis
05/2002
1Tissue Adhesions
04/2002
1Stomach Neoplasms (Stomach Cancer)
04/2002
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2002
1Fatty Liver
02/2002
1Esophageal Neoplasms (Esophageal Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

35AdiponectinIBA
04/2008 - 01/2002
6Simvastatin (Zocor)FDA LinkGeneric
08/2008 - 12/2002
6AdipokinesIBA
05/2006 - 01/2003
4CholesterolIBA
08/2008 - 12/2002
4Lipoproteins (Lipoprotein)IBA
03/2005 - 05/2003
2C-Reactive ProteinIBA
01/2005 - 03/2004
2ApolipoproteinsIBA
06/2003 - 11/2002
2Epidermal Growth Factor (EGF)IBA
04/2002 - 01/2002
1Eicosapentaenoic AcidIBA
07/2008
1NeuropeptidesIBA
03/2007
1secretogranin IIIIBA
03/2007
1Plasminogen Activators (Plasminogen Activator)IBA
12/2005
1Glucose (Dextrose)FDA LinkGeneric
09/2005
1rosiglitazone (Avandia)FDA Link
06/2004
1Ephrin-B1 (Ephrin B1)IBA
12/2003
1Carbon Tetrachloride (Tetrachloromethane)IBA
12/2003
1Adrenocorticotropic Hormone (ACTH)FDA Link
10/2003
1Matrix MetalloproteinasesIBA
09/2003
1BezafibrateIBA
08/2003
1atorvastatin (Lipitor)FDA Link
06/2003
1imatinib (Gleevec)FDA Link
05/2003
1HDL CholesterolIBA
01/2003
1HormonesIBA
11/2002
1LeptinIBA
05/2002
1Ganciclovir (Cytovene)FDA LinkGeneric
05/2002
1heparin-binding EGF-like growth factor (HB-EGF)IBA
04/2002
1Protein Tyrosine PhosphatasesIBA
04/2002
1Heparin (Liquaemin)FDA LinkGeneric
04/2002
1Cyclin D1IBA
02/2002
1PPAR gammaIBA
02/2002
1microsomal triglyceride transfer proteinIBA
02/2002
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2002
1rosuvastatin (Crestor)FDA Link
01/2002

Therapy/Procedure

2Highly Active Antiretroviral Therapy (HAART)
06/2004 - 04/2003
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2002